Blood pressure and hypertension: findings from 20 years of the Tehran lipid and glucose study [TLGS]
International Journal of Endocrinology and Metabolism. 2018; 16 (4 Supp.): 79-86
Dans Anglais
| IMEMR
| ID: emr-204933
ABSTRACT
Context hypertension [HTN] is a well-known modifiable risk factor for cardiovascular disease [CVD], chronic kidney disease and mortality. Positive effects of blood pressure [BP] lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials
Recherche sur Google
Indice:
Méditerranée orientale
Type d'étude:
Essai clinique contrôlé
langue:
Anglais
Texte intégral:
Int. J. Endocrinol. Metab.
Année:
2018
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS